Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology

Condition(s) studied

Investigational drug(s) / intervention(s)

Gastric Cancer AI-driven Data Integration Genomic Analysis Biomarker: Enter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis

Study summary

This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.

Eligibility

Primary outcome measure(s)

• 5-year overall survival — 2025-12-31
  5-year overall survival

Trial sites (1)

More Qun Zhao trials in China